The start of 2022 saw Aculabs roll out several new features to our online web portal, including Email Reporting for Result Notification and improved logic used in our Exception Test Flagging feature. The purpose of such functionality is to continue expanding the ways Aculabs communicates with your staff while tackling patient care. Such features
Aculabs will be offering QuantiFERON-TB Gold Plus in-house as of April 6, 2022; the test provides highly accurate and reproducible results, single-step testing, and innovative CD8 T cell technology that provides a more comprehensive view of the immune response to TB infection. Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb). A person infected with MTB might end up with TB disease with clinical, radiographic, and microbiological evidence of tuberculosis, or will have no clinical evidence of TB disease and would be considered latent tuberculosis infection (LTBI); however, about 10% with LTBI will progress or
Please be aware that several send-out tests will be temporarily unavailable to order, as supply shortages impacting the grey and pink parapak kits used for the collection of stool specimen have impacted the reference laboratories in which Aculabs utilizes for such send-out testing. The following are the most commonly ordered tests to be impacted:
As an industry leader, Aculabs values the way in which our digital and technological systems can always be improved to continually optimize the user experience. Our Online Web Portal remains the main hub for which many clients can 1) most easily place orders and 2) receive order results in the shortest time possible, necessary
In a new memo, the United States Food & Drug Administration (FDA) has documented and warned both patients and healthcare providers of the risk of Omicron, the latest variant of SARS-CoV-2, displaying reduced sensitivity to rapid antigen tests. Rapid antigen tests, sometimes referred to as lateral flow tests, are often used in occupational and
In a recent newsletter announcement, the Centers for Disease Control and Prevention warned of a shortage occurring for COVID-19 rapid tests. In this advisory, the CDC advised diagnostic service providers to expect an increase in the demand for laboratory-based COVID-19 testing due to a shortage in supply for both point-of-care testing and rapid testing
The New Jersey Department of Health has asked for all healthcare providers and long-term care facilities in the state to alert them of SARS‐CoV‐2 positive respiratory specimens when vaccine failure is suspected so that genomic sequencing can be performed. Per the guidance: “Because most commercial laboratories retain respiratory specimens only a couple days, once
Respiratory tract infection is one of the most frequent and fatal infections in the geriatric population. Long-term Care Facilities (LTCF) residents are prone to infection because of the decrease in their immunity, their impaired cognitive function, frailty, congregated setting, the kinds of medication taken, and the presence of many underlying factors like diabetes or
Over the past 6 months, there has been unprecedented demand for Sodium Citrate tubes due to the COVID-19 pandemic and alternative vendor supply challenges. Due to their use in monitoring a person's clotting time, especially if they are on blood thinners such as Coumadin, they are a staple in delivering diagnostic services to long-term